[go: up one dir, main page]

MA42681B1 - Ezh2 inhibitors - Google Patents

Ezh2 inhibitors

Info

Publication number
MA42681B1
MA42681B1 MA42681A MA42681A MA42681B1 MA 42681 B1 MA42681 B1 MA 42681B1 MA 42681 A MA42681 A MA 42681A MA 42681 A MA42681 A MA 42681A MA 42681 B1 MA42681 B1 MA 42681B1
Authority
MA
Morocco
Prior art keywords
compounds
ezh2 inhibitors
tumors
ezh2
enhancer
Prior art date
Application number
MA42681A
Other languages
French (fr)
Inventor
Michael John Rodriguez
Esteban Dominguez
Deqi Guo
Mary Margaret Mader
Anh-Quan Hannah Nguyen
Prado Miriam Filadelfa Del
Michael Enrico Richett
Yvonne Yee Mai Yip
Kuo-Long Yu
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority claimed from PCT/US2016/047989 external-priority patent/WO2017035060A1/en
Publication of MA42681B1 publication Critical patent/MA42681B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des composés qui inhibent l'activité de l'histone lysine n-méthyltransférase ezh2 (enhancer of zeste homolog 2), des compositions pharmaceutiques comprenant ces composés, et des méthodes d'utilisation de ces composés pour traiter le cancer, par exemple les tumeurs hématologiques et les tumeurs solides.The present invention relates to compounds which inhibit the activity of the histone lysine n-methyltransferase ezh2 (enhancer of zeste homolog 2), pharmaceutical compositions comprising these compounds, and methods of using these compounds to treat cancer, for example example haematological tumors and solid tumors.

MA42681A 2015-08-27 2016-08-22 Ezh2 inhibitors MA42681B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15382433 2015-08-27
PCT/US2016/047989 WO2017035060A1 (en) 2015-08-27 2016-08-22 Inhibitors of ezh2

Publications (1)

Publication Number Publication Date
MA42681B1 true MA42681B1 (en) 2020-01-31

Family

ID=54145713

Family Applications (1)

Application Number Title Priority Date Filing Date
MA42681A MA42681B1 (en) 2015-08-27 2016-08-22 Ezh2 inhibitors

Country Status (2)

Country Link
AR (1) AR105666A1 (en)
MA (1) MA42681B1 (en)

Also Published As

Publication number Publication date
AR105666A1 (en) 2017-10-25

Similar Documents

Publication Publication Date Title
MX2020013649A (en) Compositions and methods for inhibiting arginase activity.
EA201591823A1 (en) IDO INHIBITORS
MX2017012730A (en) Inhibitors of indoleamine 2,3-dioxygenase for the treatment of cancer.
PH12018500423A1 (en) Inhibitors of ezh2
MX366875B (en) Ido inhibitors.
MX2016002075A (en) Ido inhibitors.
EA201591599A1 (en) IDO INHIBITORS
MX2015017486A (en) Ido inhibitors.
EA201891057A1 (en) COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY
MX373373B (en) LYSINE-SPECIFIC DEMETHYLASE-1 INHIBITORS.
JOP20210158A1 (en) Modulators of hsd17b13 expression
MA47736B1 (en) Pyrimidopyrimidinones useful as wee-1 kinase inhibitors
MX2017015923A (en) Ido inhibitors.
MA43052B1 (en) Human Plasma Kallikrein Inhibitors
MA42681B1 (en) Ezh2 inhibitors
MA43158B1 (en) Oxa-diazadispiro compounds with activity against pain
EA202190125A1 (en) PYRIDOPYRIMIDINONE DERIVATIVES FOR USE AS Axl INHIBITORS
EA202191138A1 (en) COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY
EA201991517A1 (en) COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY
EA201892527A1 (en) INHIBER INHIBITORS HOMOLOGIST 2 ZESTE PROTEIN